Notes
The development of the cost-consequence model was funded by Nestlé S.A., the manufacturer of semi-elemental and polymeric enteral nutrition formulas.
Reference
Curry AS, et al. Early introduction of a semi-elemental formula may be cost saving compared to a polymeric formula among critically ill patients requiring enteral nutrition: a cohort cost-consequence model. ClinicoEconomics and Outcomes Research : 5 Jun 2018. Available from: URL: https://doi.org/10.2147/CEOR.S155312
Rights and permissions
About this article
Cite this article
Semi-elemental enteral nutrition reduces ICU costs. PharmacoEcon Outcomes News 805, 31 (2018). https://doi.org/10.1007/s40274-018-5033-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5033-9